ASN
RVMD icon

Advisory Services Network’s Revolution Medicines RVMD Stock Holding History

Advisory Services Network’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-467
Closed -$45.4K – 4145
2026
Q1 		$45.4K Buy
+467
New +$47.2K ﹤0.01% 2693
2025
Q4 		– Sell
-417
Closed -$19.5K – 3776
2025
Q3 		$19.5K Buy
+417
New +$16.3K ﹤0.01% 2959

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Advisory Services Network's RVMD Position: Q2 2026 in Review

Advisory Services Network sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 467 shares — an estimated $45.4K sold.

Advisory Services Network first reported a position in RVMD in Q3 2025 and held it in 2 quarters. The position peaked at $45.4K in Q1 2026. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Advisory Services Network reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 467 Revolution Medicines shares in Q2 2026, an estimated $45.4K.
  • Advisory Services Network first reported a position in Revolution Medicines in Q3 2025 and held it in 2 quarters.
  • Advisory Services Network's Revolution Medicines position peaked at $45.4K in Q1 2026.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.